1. An Open‐Label, Randomized, Pivotal Bioequivalence Study of Oral Rolapitant. Issue 2 (9th January 2019) Authors: Zhang, Zhi‐Yi; Wang, Jing; Arora, Sujata; Lu, Sharon; Powers, Dan; Kansra, Vikram; Wang, Xiaodong Journal: Clinical pharmacology in drug development Issue: Volume 8:Issue 2(2019) Page Start: 152 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Bioequivalence of Intravenous and Oral Rolapitant: Results From a Randomized, Open‐Label Pivotal Study. (14th September 2017) Authors: Wang, Xiaodong; Zhang, Zhi‐Yi; Powers, Daniel; Wang, Jing; Lu, Sharon; Arora, Sujata; Hughes, Lorraine; Christensen, Jennifer; Kansra, Vikram Journal: Journal of clinical pharmacology Issue: Volume 57:Number 12(2017) Page Start: 1600 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Comparative analysis of PD‐1 target engagement of dostarlimab and pembrolizumab in advanced solid tumors using ex vivo IL‐2 stimulation data. (16th November 2022) Authors: Austin, Daren; Melhem, Murad; Gandhi, Yash; Lu, Sharon; Visser, Sandra Journal: CPT: pharmacometrics & systems pharmacology Issue: Volume 12:Number 1(2023) Page Start: 87 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Effects of Rolapitant Administered Intravenously on the Pharmacokinetics of a Modified Cooperstown Cocktail (Midazolam, Omeprazole, Warfarin, Caffeine, and Dextromethorphan) in Healthy Subjects. (25th April 2018) Authors: Wang, Xiaodong; Zhang, Zhi‐Yi; Arora, Sujata; Wang, Jing; Lu, Sharon; Powers, Dan; Kansra, Vikram Journal: Journal of clinical pharmacology Issue: Volume 58:Number 8(2018) Page Start: 1074 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. Effects of Rolapitant Administered Intravenously or Orally on the Pharmacokinetics of Digoxin (P‐glycoprotein Substrate) and Sulfasalazine (Breast Cancer Resistance Protein Substrate) in Healthy Volunteers. (14th September 2017) Authors: Wang, Xiaodong; Zhang, Zhi‐Yi; Arora, Sujata; Hughes, Lorraine; Wang, Jing; Powers, Daniel; Christensen, Jennifer; Lu, Sharon; Kansra, Vikram Journal: Journal of clinical pharmacology Issue: Volume 58:Number 2(2018) Page Start: 202 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. IOLite: phase 1b trial of doublet/triplet combinations of dostarlimab with niraparib, carboplatin–paclitaxel, with or without bevacizumab in patients with advanced cancer. Issue 3 (24th March 2022) Authors: Yap, Timothy A; Bessudo, Alberto; Hamilton, Erika; Sachdev, Jasgit; Patel, Manish R; Rodon, Jordi; Evilevitch, Lena; Duncan, Meghan; Guo, Wei; Kumar, Sujatha; Lu, Sharon; Dezube, Bruce J; Gabrail, Nashat Journal: Journal for immunotherapy of cancer Issue: Volume 10:Issue 3(2022) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. JASPER: Phase 2 trial of first‐line niraparib plus pembrolizumab in patients with advanced non–small cell lung cancer. Issue 1 (3rd September 2021) Authors: Ramalingam, Suresh S.; Thara, Eddie; Awad, Mark M.; Dowlati, Afshin; Haque, Basir; Stinchcombe, Thomas E.; Dy, Grace K.; Spigel, David R.; Lu, Sharon; Iyer Singh, Nithya; Tang, Yongqiang; Teslenko, Iryna; Iannotti, Nicholas Journal: Cancer Issue: Volume 128:Issue 1(2022) Page Start: 65 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. Pharmacokinetic Interactions of Rolapitant With Cytochrome P450 3A Substrates in Healthy Subjects. (13th November 2018) Authors: Wang, Xiaodong; Wang, Jing; Arora, Sujata; Hughes, Lorraine; Christensen, Jennifer; Lu, Sharon; Zhang, Zhi‐Yi Journal: Journal of clinical pharmacology Issue: Volume 59:Number 4(2019) Page Start: 488 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. Pharmacokinetics of Rolapitant in Patients With Mild to Moderate Hepatic Impairment. (12th January 2018) Authors: Wang, Jing; Wang, Xiaodong; Zhang, Zhi‐Yi; Arora, Sujata; Lu, Sharon; Kansra, Vikram Journal: Journal of clinical pharmacology Issue: Volume 58:Number 5(2018) Page Start: 686 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
10. Pharmacokinetics, Safety, and Tolerability of Rolapitant Administered Intravenously Following Single Ascending and Multiple Ascending Doses in Healthy Subjects. Issue 2 (15th June 2018) Authors: Wang, Xiaodong; Zhang, Zhi‐Yi; Wang, Jing; Powers, Dan; Arora, Sujata; Lu, Sharon; Kansra, Vikram Journal: Clinical pharmacology in drug development Issue: Volume 8:Issue 2(2019) Page Start: 160 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗